Markets always seem to overdiscount known risks and underdiscount unknowns; the risks are known here, and the deal is solid, I reckon we will see massive upside from here.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025